Walter V. Klemp - Jun 22, 2024 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Jonathan P. Foster by Power of Attorney
Stock symbol
MBRX
Transactions as of
Jun 22, 2024
Transactions value $
-$8,191
Form type
4
Date filed
6/25/2024, 06:00 PM
Previous filing
Jun 24, 2024
Next filing
Jul 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBRX Common Stock Options Exercise +8.99K +18.16% 58.5K Jun 22, 2024 Direct F1
transaction MBRX Common Stock Tax liability -$8.19K -2.19K -3.74% $3.74 56.3K Jun 22, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Restricted Stock Units Options Exercise $0 -8.99K -7.3% $0.00 114K Jun 22, 2024 Common Stock 8.99K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
F3 On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.